Tagged with P

EFPIA The European Commission recently announced a new industrial strategy and pharmaceutical roadmap, largely focused on revising legislation dating back nearly two decades, with the aim of laying out a concrete plan by the end of 2020. The commission’s priority is to revitalize medical innovation in Europe, a chief concern voiced…

Coronavirus During a global virtual press briefing on 19 March 2020, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) gathered five global pharmaceutical leaders including Eli Lilly Chairman and CEO David A. Ricks, who is also the president of IFPMA for 2019-2020, to discuss the global ramifications of the COVID-19…

Belgium Bertrand Duquesne, managing director of Boiron Belgium, elaborates on the challenges being faced by homeopathy manufacturers in western Europe and explains how the company and its peers are create dialogue about these products in the country with the newly formed Homeopathy Belgium Industry Association.   In 2017, 44 percent of…

Czech Republic Roman Samiec, general manager of Thuasne Czech Republic, introduces the company as a key competitor in the medical devices field, with their niche products addressing the unmet medical need in the country including orthoses and homecare. Samiec describes the significant history of the French firm in the Czech Republic and…

Mexico Arturo Prida Romero, the president of the current National Council of the Partido de la Revolución Democrática (PRD) – one of the main political parties in Mexico – shares the background of PRD’s agenda, focusing on education, public security and healthcare as the three pillars of public service; the importance…

Czech Republic Miroslav Palát, president of CzechMed, the medical device association in the Czech Republic, and Jiří Pavlíček, who combines the responsibility of Chairman of the association and CEO of the medtech distributor Aspironix, share the challenges that medtech companies are facing in the country and the strategic direction that CzechMed aims…

UAE The Saudi German Hospital Group is one of the leading hospital groups in the Middle East, with hospitals in the UAE, Saudi Arabia, Yemen and Egypt. Dr Reem Osman, CEO for the Group in the UAE, discusses their presence in the country, the Group’s ambitious expansion plans and analyses the…

Morocco Sanaa Sayagh of Roche Morocco shares her commitment to bringing the latest immunotherapies to Moroccan patients through partnerships with health authorities and the Lalla Salma Foundation on creative access programs. Sayagh also touches on how Roche is attempting to make personalised healthcare a reality in Morocco.   Despite the lack…

Belgium PDC*Line Pharma’s Eric Halioua introduces the Belgian immuno-oncology biotech, its clinical-stage assets, the impact of the firm’s collaboration with Korean LG Chem, and future internationalisation strategies.   As a multicultural company, we believe in the future growth of Belgium’s innovative biotechnology sector. It is absolutely a country which should be…

Czech Republic Pavla Nevolová, country head of EastHORN in the Czech Republic, shares the historical roots of the now multinational Czech CRO. Nevolová also shares her insights into the recent evolution of the Czech clinical research landscape and its challenges and opportunities.   Without any doubt, my biggest achievement at EastHORN is…

Global Charlotte Kremer is head of medical affairs for Astellas Pharma and serves as the president of the Medical Affairs Professional Society. At eyeforpharma Barcelona by Reuters Events 2020, a virtual conference held between March 31 and April 3, Kremer spoke on the evolving strategic role of medical affairs in driving…

Russia Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association and new breakthroughs in Coronavirus diagnostics.   Government amends legislation around emergency response to diseases The State Duma, as is…